{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:47:39Z","timestamp":1782719259049,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00213236"],"award-info":[{"award-number":["RS-2023-00213236"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13258-026-01764-w","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:53:28Z","timestamp":1776239608000},"page":"963-974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["5-Aminoimidazole-4-carboxamide riboside, an AMPK activator, enhances TRAIL-mediated apoptosis in human bladder cancer cells in a p38 MAPK-dependent manner"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4906-0410","authenticated-orcid":false,"given":"Cheol","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2180-1205","authenticated-orcid":false,"given":"Hyun","family":"Hwangbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9291-5803","authenticated-orcid":false,"given":"Su Hyun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3350-434X","authenticated-orcid":false,"given":"Hyeon Ji","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-4746","authenticated-orcid":false,"given":"Seok Joong","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4987-7802","authenticated-orcid":false,"given":"Jeong Sook","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4514-3457","authenticated-orcid":false,"given":"Sung-Kwon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8060-8926","authenticated-orcid":false,"given":"Wun-Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6878-0790","authenticated-orcid":false,"given":"Gi-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-3124","authenticated-orcid":false,"given":"Yung Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"1764_CR1","doi-asserted-by":"publisher","first-page":"1453278","DOI":"10.3389\/fonc.2024.1453278","volume":"14","author":"M Ahangar","year":"2024","unstructured":"Ahangar M, Mahjoubi F, Mowla SJ (2024) Bladder cancer biomarkers: current approaches and future directions. Front Oncol 14:1453278. https:\/\/doi.org\/10.3389\/fonc.2024.1453278","journal-title":"Front Oncol"},{"issue":"7","key":"1764_CR2","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/cdd.2013.28","volume":"20","author":"K Azijli","year":"2013","unstructured":"Azijli K, Weyhenmeyer B, Peters GJ, de Jong S, Kruyt FA (2013) Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family. Cell Death Differ 20(7):858\u2013868. https:\/\/doi.org\/10.1038\/cdd.2013.28","journal-title":"Cell Death Differ"},{"issue":"1","key":"1764_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12885-023-11021-y","volume":"23","author":"SM Babazadeh","year":"2023","unstructured":"Babazadeh SM, Zolfaghari MR, Zargar M, Baesi K, Hosseini SY, Ghaemi A (2023) Interleukin-24-mediated antitumor effects against human glioblastoma via upregulation of p38 MAPK and endogenous TRAIL-induced apoptosis and LC3-II activation-dependent autophagy. BMC Cancer 23(1):519. https:\/\/doi.org\/10.1186\/s12885-023-11021-y","journal-title":"BMC Cancer"},{"key":"1764_CR4","doi-asserted-by":"publisher","first-page":"32111","DOI":"10.1038\/srep32111","volume":"6","author":"M Bo\u00df","year":"2016","unstructured":"Bo\u00df M, Newbatt Y, Gupta S, Collins I, Br\u00fcne B, Namgaladze D (2016) AMPK-independent inhibition of human macrophage ER stress response by AICAR. Sci Rep 6:32111. https:\/\/doi.org\/10.1038\/srep32111","journal-title":"Sci Rep"},{"key":"1764_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bcp.2018.10.019","volume":"158","author":"HS Byun","year":"2018","unstructured":"Byun HS, Zhou W, Park I, Kang K, Lee SR, Piao X, Park JB, Kwon TK, Na M, Hur GM (2018) C-27-carboxylated oleanane triterpenoids up-regulate TRAIL DISC assembly via p38 MAPK and CHOP-mediated DR5 expression in human glioblastoma cells. Biochem Pharmacol 158:243\u2013260. https:\/\/doi.org\/10.1016\/j.bcp.2018.10.019","journal-title":"Biochem Pharmacol"},{"key":"1764_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2147\/BTT.S538522","volume":"19","author":"R Cao","year":"2025","unstructured":"Cao R, Qi W, Huang X, Zheng Y, Zheng R, Ma Y, Zhang H (2025) The dual role of the TRAIL-DR5 signaling axis in cardiovascular disease: From molecular mechanisms to targeted therapies. Biologics 19:613\u2013629. https:\/\/doi.org\/10.2147\/BTT.S538522","journal-title":"Biologics"},{"key":"1764_CR44","doi-asserted-by":"publisher","unstructured":"CharguiA, Hammami I, Hashem A, Al-Hazzani AA, Abd Allah EF, Belaid A, Marzougui S, Elmay MV, Mograbi B (2025) Cd stabilizes HIF-1\u03b1 under normoxic conditions via lysine-63-linked ubiquitination and induces ER stress and cell proliferation. Toxicol Res 41(3):221-234. https:\/\/doi.org\/10.1007\/s43188-024-00266-9","DOI":"10.1007\/s43188-024-00266-9"},{"issue":"5","key":"1764_CR7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/cells10051067","volume":"10","author":"D Conza","year":"2021","unstructured":"Conza D, Mirra P, Cal\u00ec G, Insabato L, Fiory F, Beguinot F, Ulianich L (2021) Metformin dysregulates the unfolded protein response and the WNT\/\u03b2-catenin pathway in endometrial cancer cells through an AMPK-independent mechanism. Cells 10(5):1067. https:\/\/doi.org\/10.3390\/cells10051067","journal-title":"Cells"},{"issue":"3","key":"1764_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.7150\/ijbs.30847","volume":"15","author":"Y Deng","year":"2019","unstructured":"Deng Y, Bi R, Guo H, Yang J, Du Y, Wang C, Wei W (2019) Andrographolide enhances TRAIL-induced apoptosis via p53-mediated death receptors up-regulation and suppression of the NF-kB pathway in bladder cancer cells. Int J Biol Sci 15(3):688\u2013700. https:\/\/doi.org\/10.7150\/ijbs.30847","journal-title":"Int J Biol Sci"},{"issue":"7","key":"1764_CR9","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/cancers13071543","volume":"13","author":"OA Diaz Arguello","year":"2021","unstructured":"Diaz Arguello OA, Haisma HJ (2021) Apoptosis-inducing TNF superfamily ligands for cancer therapy. Cancers (Basel) 13(7):1543. https:\/\/doi.org\/10.3390\/cancers13071543","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1764_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bbrc.2017.02.059","volume":"485","author":"MG Dilshara","year":"2017","unstructured":"Dilshara MG, Jeong JW, Prasad Tharanga Jayasooriya RG, Neelaka Molagoda IM, Lee S, Park SR, Choi YH, Kim GY (2017) Glutamine deprivation sensitizes human breast cancer MDA-MB-231 cells to TRIAL-mediated apoptosis. Biochem Biophys Res Commun 485(2):440\u2013445. https:\/\/doi.org\/10.1016\/j.bbrc.2017.02.059","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1764_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.bcp.2009.10.022","volume":"79","author":"C Garc\u00eda-Garc\u00eda","year":"2010","unstructured":"Garc\u00eda-Garc\u00eda C, Fumarola C, Navaratnam N, Carling D, L\u00f3pez-Rivas A (2010) AMPK-independent down-regulation of cFLIP and sensitization to TRAIL-induced apoptosis by AMPK activators. Biochem Pharmacol 79(6):853\u2013863. https:\/\/doi.org\/10.1016\/j.bcp.2009.10.022","journal-title":"Biochem Pharmacol"},{"key":"1764_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2019.12.001","volume":"351","author":"JA Glab","year":"2020","unstructured":"Glab JA, Cao Z, Puthalakath H (2020) Bcl-2 family proteins, beyond the veil. Int Rev Cell Mol Biol 351:1\u201322. https:\/\/doi.org\/10.1016\/bs.ircmb.2019.12.001","journal-title":"Int Rev Cell Mol Biol"},{"key":"1764_CR13","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.22092.1","author":"J Han","year":"2020","unstructured":"Han J, Wu J, Silke J (2020) An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling. F1000Research. https:\/\/doi.org\/10.12688\/f1000research.22092.1","journal-title":"F1000Research"},{"issue":"12","key":"1764_CR14","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1002\/tox.23372","volume":"36","author":"CC Huang","year":"2021","unstructured":"Huang CC, Cheng YC, Lin YC, Chou CH, Ho CT, Wang HK, Way TD (2021) CSC-3436 sensitizes triple negative breast cancer cells to TRAIL-induced apoptosis through ROS-mediated p38\/CHOP\/death receptor 5 signaling pathways. Environ Toxicol 36(12):2578\u20132588. https:\/\/doi.org\/10.1002\/tox.23372","journal-title":"Environ Toxicol"},{"issue":"2","key":"1764_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.15171\/apb.2019.024","volume":"9","author":"R Jan","year":"2019","unstructured":"Jan R, Chaudhry GE (2019) Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Adv Pharm Bull 9(2):205\u2013218. https:\/\/doi.org\/10.15171\/apb.2019.024","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"1764_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3892\/ol.2017.6223","volume":"14","author":"KH Kang","year":"2017","unstructured":"Kang KH, Han MH, Jeong JW, Park C, Lee SH, Lee HW, Hong SH, Choi YH, Hong SH (2017) Bufalin sensitizes human bladder carcinoma cells to TRAIL-mediated apoptosis. Oncol Lett 14(1):853\u2013859. https:\/\/doi.org\/10.3892\/ol.2017.6223","journal-title":"Oncol Lett"},{"issue":"5","key":"1764_CR17","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/molecules26051381","volume":"26","author":"SY Kim","year":"2021","unstructured":"Kim SY, Hwangbo H, Kim MY, Ji SY, Kim DH, Lee H, Kim GY, Moon SK, Leem SH, Yun SJ, Kim WJ, Cheong J, Park C, Choi YH (2021) Betulinic acid restricts human bladder cancer cell proliferation in vitro by inducing caspase-dependent cell death and cell cycle arrest, and decreasing metastatic potential. Molecules 26(5):1381. https:\/\/doi.org\/10.3390\/molecules26051381","journal-title":"Molecules"},{"issue":"3","key":"1764_CR18","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s12257-025-00194-x","volume":"30","author":"JS Kim","year":"2025","unstructured":"Kim JS, Son H, Han J, Cha H, Lee JH, Pack SP, Lee CS (2025) Evaluation of mitochondrial activity via cellular interactions between adrenal and neuronal cells in a microfluidic coculture device. Biotechnol Bioprocess Eng 30(3):502\u2013519. https:\/\/doi.org\/10.1007\/s12257-025-00194-x","journal-title":"Biotechnol Bioprocess Eng"},{"issue":"1","key":"1764_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42826-025-00245-7","volume":"41","author":"J Lee","year":"2025","unstructured":"Lee J, Park JR, Lee H, Hong SH, Kim WJ, Eickelberg O, Park SM, Ryu S, Cho SJ, Kim SJ, Yang SR (2025) Fludarabine attenuates inflammation and dysregulated autophagy in alveolar macrophages via inhibition of STAT1\/IRF1 pathway. Lab Anim Res 41(1):12. https:\/\/doi.org\/10.1186\/s42826-025-00245-7","journal-title":"Lab Anim Res"},{"issue":"5","key":"1764_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12032-022-01663-6","volume":"39","author":"W Liu","year":"2022","unstructured":"Liu W, Wang S, Yang Q, Feng X, Yu B, Yu X (2022) 20(s)-ginsenoside Rh2 promotes TRAIL-induced apoptosis by upregulating DR5 in human hepatocellular carcinoma cells. Med Oncol 39(5):70. https:\/\/doi.org\/10.1007\/s12032-022-01663-6","journal-title":"Med Oncol"},{"issue":"1","key":"1764_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/his.15555","volume":"88","author":"A Lopez-Beltran","year":"2026","unstructured":"Lopez-Beltran A, Blanca A, Downes MR, Cimadamore A, Montironi R, Cheng L (2026) Molecular pathology of bladder cancer. Histopathology 88(1):65\u201385. https:\/\/doi.org\/10.1111\/his.15555","journal-title":"Histopathology"},{"issue":"6","key":"1764_CR22","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3390\/ijms21061913","volume":"21","author":"A Mart\u00ednez-Lim\u00f3n","year":"2020","unstructured":"Mart\u00ednez-Lim\u00f3n A, Joaquin M, Caballero M, Posas F, de Nadal E (2020) The p38 pathway: From biology to cancer therapy. Int J Mol Sci 21(6):1913. https:\/\/doi.org\/10.3390\/ijms21061913","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1764_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.59249\/JKBB6336","volume":"98","author":"SS Mohanty","year":"2025","unstructured":"Mohanty SS, Warrier S, Rangarajan A (2025) Rethinking AMPK: A reversible switch fortifying cancer cell stress-resilience. Yale J Biol Med 98(1):33\u201352. https:\/\/doi.org\/10.59249\/JKBB6336","journal-title":"Yale J Biol Med"},{"issue":"2","key":"1764_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41418-022-01059-z","volume":"30","author":"A Montinaro","year":"2023","unstructured":"Montinaro A, Walczak H (2023) Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries. Cell Death Differ 30(2):237\u2013249. https:\/\/doi.org\/10.1038\/s41418-022-01059-z","journal-title":"Cell Death Differ"},{"issue":"1","key":"1764_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","volume":"20","author":"A Moyer","year":"2025","unstructured":"Moyer A, Tanaka K, Cheng EH (2025) Apoptosis in cancer biology and therapy. Annu Rev Pathol 20(1):303\u2013328. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-051222-115023","journal-title":"Annu Rev Pathol"},{"issue":"14","key":"1764_CR26","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1042\/BCJ20210352","volume":"481","author":"D Nguyen","year":"2024","unstructured":"Nguyen D, Osterlund E, Kale J, Andrews DW (2024) The C-terminal sequences of Bcl-2 family proteins mediate interactions that regulate cell death. Biochem J 481(14):903\u2013922. https:\/\/doi.org\/10.1042\/BCJ20210352","journal-title":"Biochem J"},{"key":"1764_CR27","doi-asserted-by":"publisher","first-page":"151415","DOI":"10.1016\/j.bbrc.2025.151415","volume":"751","author":"KKH Niroshika","year":"2025","unstructured":"Niroshika KKH, Weerakoon K, Molagoda IMN, Samarakoon KW, Weerakoon HT, Jayasooriya RGPT (2025) Exploring the dynamic role of circulating soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a diagnostic and prognostic marker; a review. Biochem Biophys Res Commun 751:151415. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151415","journal-title":"Biochem Biophys Res Commun"},{"key":"1764_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcancer.2024.08.002","volume":"106\u2013107","author":"V Penugurti","year":"2024","unstructured":"Penugurti V, Manne RK, Bai L, Kant R, Lin HK (2024) AMPK: The energy sensor at the crossroads of aging and cancer. Semin Cancer Biol 106\u2013107:15\u201327. https:\/\/doi.org\/10.1016\/j.semcancer.2024.08.002","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"1764_CR29","doi-asserted-by":"publisher","first-page":"e28354","DOI":"10.1371\/journal.pone.0028354","volume":"6","author":"ML Plissonnier","year":"2011","unstructured":"Plissonnier ML, Fauconnet S, Bittard H, Lascombe I (2011) The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL. PLoS ONE 6(12):e28354. https:\/\/doi.org\/10.1371\/journal.pone.0028354","journal-title":"PLoS ONE"},{"issue":"23","key":"1764_CR30","doi-asserted-by":"publisher","first-page":"33783","DOI":"10.18632\/oncotarget.9277","volume":"7","author":"E Rao","year":"2016","unstructured":"Rao E, Zhang Y, Li Q, Hao J, Egilmez NK, Suttles J, Li B (2016) AMPK-dependent and independent effects of AICAR and compound C on T-cell responses. Oncotarget 7(23):33783\u201333795. https:\/\/doi.org\/10.18632\/oncotarget.9277","journal-title":"Oncotarget"},{"issue":"1","key":"1764_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.yexcr.2018.04.022","volume":"368","author":"M Rasheduzzaman","year":"2018","unstructured":"Rasheduzzaman M, Park SY (2018) Antihypertensive drug-candesartan attenuates TRAIL resistance in human lung cancer via AMPK-mediated inhibition of autophagy flux. Exp Cell Res 368(1):126\u2013135. https:\/\/doi.org\/10.1016\/j.yexcr.2018.04.022","journal-title":"Exp Cell Res"},{"issue":"2","key":"1764_CR32","doi-asserted-by":"publisher","first-page":"104299","DOI":"10.1016\/j.drudis.2025.104299","volume":"30","author":"K Rashid","year":"2025","unstructured":"Rashid K, Kalthoff H, Abdulkadir SA, Adam D (2025) Death ligand receptor (DLR) signaling: its non-apoptotic functions in cancer and the consequences of DLR-directed therapies. Drug Discov Today 30(2):104299. https:\/\/doi.org\/10.1016\/j.drudis.2025.104299","journal-title":"Drug Discov Today"},{"issue":"1","key":"1764_CR33","doi-asserted-by":"publisher","first-page":"113614","DOI":"10.1016\/j.yexcr.2023.113614","volume":"428","author":"A Sharma","year":"2023","unstructured":"Sharma A, Anand SK, Singh N, Dwivedi UN, Kakkar P (2023) AMP-activated protein kinase: an energy sensor and survival mechanism in the reinstatement of metabolic homeostasis. Exp Cell Res 428(1):113614. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113614","journal-title":"Exp Cell Res"},{"issue":"2","key":"1764_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bcp.2014.07.010","volume":"91","author":"B Sid","year":"2014","unstructured":"Sid B, Glorieux C, Valenzuela M, Rommelaere G, Najimi M, Dejeans N, Renard P, Verrax J, Calderon PB (2014) AICAR induces Nrf2 activation by an AMPK-independent mechanism in hepatocarcinoma cells. Biochem Pharmacol 91(2):168\u2013180. https:\/\/doi.org\/10.1016\/j.bcp.2014.07.010","journal-title":"Biochem Pharmacol"},{"key":"1764_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12257-024-00167-6","volume":"30","author":"M Song","year":"2025","unstructured":"Song M, Cheon J, Kwon S (2025) Enhanced cytotoxicity of natural killer cells with Zn-alginate hydrogel microspheres. Biotechnol Bioprocess Eng 30:30\u201341. https:\/\/doi.org\/10.1007\/s12257-024-00167-6","journal-title":"Biotechnol Bioprocess Eng"},{"issue":"5","key":"1764_CR36","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1158\/1535-7163.MCT-06-0800","volume":"6","author":"RY Su","year":"2007","unstructured":"Su RY, Chao Y, Chen TY, Huang DY, Lin WW (2007) 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF\u03b1-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling. Mol Cancer Ther 6(5):1562\u20131571. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0800","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"1764_CR37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2478\/v10042-009-0111-2","volume":"47","author":"E Szliszka","year":"2009","unstructured":"Szliszka E, Mazur B, Zydowicz G, Czuba ZP, Kr\u00f3l W (2009) TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells. Folia Histochem Cytobiol 47(4):579\u2013585. https:\/\/doi.org\/10.2478\/v10042-009-0111-2","journal-title":"Folia Histochem Cytobiol"},{"issue":"5","key":"1764_CR38","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3390\/cells10051095","volume":"10","author":"D Vi\u0161nji\u0107","year":"2021","unstructured":"Vi\u0161nji\u0107 D, Lali\u0107 H, Dembitz V, Tomi\u0107 B, Smoljo T (2021) AICAr, a widely used AMPK activator with important AMPK-independent effects: a systematic review. Cells 10(5):1095. https:\/\/doi.org\/10.3390\/cells10051095","journal-title":"Cells"},{"issue":"9","key":"1764_CR39","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1002\/mco2.693","volume":"5","author":"S Wang","year":"2024","unstructured":"Wang S, Guo S, Guo J, Du Q, Wu C, Wu Y, Zhang Y (2024) Cell death pathways: molecular mechanisms and therapeutic targets for cancer. MedComm 5(9):e693. https:\/\/doi.org\/10.1002\/mco2.693","journal-title":"MedComm"},{"issue":"1","key":"1764_CR40","doi-asserted-by":"publisher","first-page":"e70517","DOI":"10.1002\/cam4.70517","volume":"14","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qian X, Wang Y, Yu C, Feng L, Zheng X, Wang Y, Gong Q (2025) Turn TRAIL into better anticancer therapeutic through TRAIL fusion proteins. Cancer Med 14(1):e70517. https:\/\/doi.org\/10.1002\/cam4.70517","journal-title":"Cancer Med"},{"key":"1764_CR41","doi-asserted-by":"publisher","first-page":"1670574","DOI":"10.3389\/fonc.2025.1670574","volume":"15","author":"J Xiang","year":"2025","unstructured":"Xiang J, Luo Y, Zhang B, Ke K, Li H (2025) Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy. Front Oncol 15:1670574. https:\/\/doi.org\/10.3389\/fonc.2025.1670574","journal-title":"Front Oncol"},{"issue":"7","key":"1764_CR42","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3390\/ijms21072346","volume":"21","author":"J Yue","year":"2020","unstructured":"Yue J, L\u00f3pez JM (2020) Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci 21(7):2346. https:\/\/doi.org\/10.3390\/ijms21072346","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1764_CR43","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/jcmm.12461","volume":"19","author":"C Zhang","year":"2015","unstructured":"Zhang C, Shi J, Mao SY, Xu YS, Zhang D, Feng LY, Zhang B, Yan YY, Wang SC, Pan JP, Yang YP, Lin NM (2015) Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT-737. J Cell Mol Med 19(2):408\u2013417. https:\/\/doi.org\/10.1111\/jcmm.12461","journal-title":"J Cell Mol Med"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-026-01764-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-026-01764-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-026-01764-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:20:56Z","timestamp":1782717656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-026-01764-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1764"],"URL":"https:\/\/doi.org\/10.1007\/s13258-026-01764-w","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}